Practo
Doctor discovery, telehealth, and clinic/hospital software platform, India based, expanding to US.
On the record
Checkpoint: Close of reported $100-125M pre-IPO round and SEBI DRHP filing for planned 2027 IPO
The call
Practo's clinic software keeps hospitals locked in, but its consumer marketplace sits flat in India while Apollo, Tata 1mg, and untested AI search reshape how patients find care.
Practo runs a marketplace where patients find doctors and book appointments, plus software that clinics and hospitals use to manage their operations. In India, the company is losing to Apollo 24/7 (which is backed by a major hospital chain and can send patients directly to its own doctors) and Tata 1mg (which is backed by a pharmacy and can steer people to doctors who prescribe their medicines). Practo's own doctor network and booking app cannot match these built-in advantages. The company is betting big on the United States market to prove its value, but that plan has not been tested yet, and it is hard to know if the promised numbers are real.
Why
01
AI pressure: General AI search and chat agents (Google AI Overviews, ChatGPT) answering health queries directly. AI agents could answer 'find me a doctor' queries directly, bypassing Practo's discovery front-door before users ever open the app. Could AI do the core job? Only partly.
02
Bigger players: Apollo 24/7 and Tata 1mg. Hospital-backed Apollo and pharmacy-backed Tata 1mg run live rival marketplaces with supply-chain ties Practo cannot replicate. Could a giant copy it? Probably.
03
What protects it. 17 years of provider relationships plus Ray and Insta clinic/hospital software that hospitals rely on for daily operations.
What would change this call
Practo India marketplace revenue figure for FY26 filing. Shows whether flat ~₹234-240cr core revenue reverses or keeps stagnating.
Apollo 24/7 or Tata 1mg publish doctor-consult or market-share numbers vs Practo. Would confirm structural advantages are converting into visible share compression.
Practo's pre-IPO round (~$100-125M at ~$700M valuation) closes or DRHP filed by Q4 2026. Confirms investor confidence and IPO path versus stalled fundraising.
Apollo 24/7 or Tata 1mg publish doctor-consult or market-share numbers vs Practo. Would confirm structural advantages are converting into visible share compression.
Practo's pre-IPO round (~$100-125M at ~$700M valuation) closes or DRHP filed by Q4 2026. Confirms investor confidence and IPO path versus stalled fundraising.
Key numbers
- FY25 India revenue flat at ~₹234 crore (~$28M)
- FY25 operating EBITDA turned positive: ₹15 crore
- US marketplace GMV crossed $100M
Named risks
- India core marketplace revenue flat near ₹234-240 crore for two straight years despite 17 years of operation.
- Pre-IPO round ($100-125M at ~$700M valuation) and 2027 IPO unconfirmed, no DRHP filed as of July 2026.
- Hiring slowdown: active job postings down 54.8% to 45 in 2026 despite growth narrative.
- Conflicting revenue disclosures (₹240cr vs ₹152cr for FY24) raise financial reporting reliability questions.
- Consumer doctor-discovery front door exposed to future disintermediation by general-purpose LLM agents.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Apollo 24/7 | gaining on | Hospital-backed network gives structural referral-conversion advantage over Practo, noted March 2026 |
| Tata 1mg | gaining on | Pharmacy supply-chain integration gives structural advantage Practo lacks, cited 2026 |
| Zocdoc / DocPlanner | contesting | International incumbents in US/Europe as Practo pushes US expansion past $100M GMV, May 2026 |
Questions people ask
- Is Practo profitable in 2026?
- Practo turned operating EBITDA positive at ₹15 crore in FY25, reversing a ₹17 crore loss in FY24, while revenue stayed roughly flat at ₹234 crore (~$28M) versus ₹240 crore the prior year, per an August 2025 report.
- Who owns Practo?
- Practo is privately held and venture-backed, with investors including Peak XV Partners, Tencent, Matrix, Sofina, Google Capital, AIA Group, Thrive Capital, Yuri Milner and Z47. Its last priced round was a $32M Series D led by AIA Group in August 2020, with total disclosed funding around $211-230M.
- Is Practo laying off employees in 2026?
- No new mass layoffs were reported in 2026, but Practo's headcount was roughly flat at 2,459 employees versus 2,508 in 2025 and down from a 2023 peak, while active job postings fell 54.8% to just 45 in 2026, signaling a hiring slowdown.
- Who is Practo's biggest competitor in India?
- Apollo 24/7, backed by Apollo Hospitals' physical network, and Tata 1mg, backed by pharmacy supply chains, are Practo's closest rivals; both have structural advantages Practo lacks in converting digital consults into referrals or drug sales, as of March 2026 analysis.
- Could AI replace Practo's doctor-discovery platform?
- As of May 2026 Practo itself used AI to handle over 20,000 daily calls and chats in its US operations, crediting AI for helping cross $100M in US GMV, making AI currently additive rather than a replacement threat, though general LLM agents could disintermediate consumer discovery long-term.
- Is Practo planning an IPO?
- Practo was in advanced talks as of February 2026 to raise $100-125M in a pre-IPO round at a roughly $700M valuation, targeting a 2027 public listing, but as of July 2026 no DRHP filing with India's SEBI had been reported.
Timeline
- 2026-05-07Practo says US marketplace crossed $100M GMV, aided by AI handling 20,000+ daily calls
- 2026-04-14Srijesh Kumar, ex-Salesforce VP, appointed Global Chief Product and Technology Officer
- 2026-03-11C.K. Mishra, former Union Health Secretary of India, joins Practo board
- 2026-03Cijo George appointed to lead Practo's AI Charter
- 2026-02-23Practo reportedly in talks to raise $100-125M pre-IPO round at ~$700M valuation
- 2025-08-05Practo reports first-ever full-year positive operating EBITDA of ₹15 crore for FY25
- 2025-08Practo launches paid US consultation/marketplace pilot with 50-60 customers
- 2023-04-08Practo lays off 41 employees, mostly engineers, amid funding winter
- 2020-08Practo raises $32M Series D led by AIA Group, its last disclosed priced round
- 2017-04-06Practo lays off 150 employees as part of annual performance cycle
Revision history
30 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Practo appoints Srijesh Kumar as Global CPTO (2026-04-14)
- Practo eyes global markets after 6 profitable quarters (2025-08-04)
- Practo Financials 2026 (2026-05-28)
- Practo aims to double international revenue in 3 years (2025-05-28)
- Practo Posts First-Ever Full-Year Operating EBITDA Ahead of IPO (2025-08-05)
- Practo appoints Srijesh Kumar (2026-04-14)
- Practo Hits $100M US GMV with AI (2026-05-07)
- Practo Funding 2026 (2026-05-28)
- Healthcare Startup Practo Lays Off 41 Employees (2023-04-11)
- Practo In Talks To Raise $100 Mn In Pre-IPO Round (2026-02-23)
- cbinsights.com (2026-07-30)
- Former Health Secretary C.K. Mishra Joins Practo Board (2026-03-11)